GE HealthCare Technologies Inc.
GEHCNASDAQHealthcareMedical Devices
As of Oct 22, 2026 close
- Market cap
- $32.42B
- P/E (TTM)
- 16.33
- Forward P/E
- 18.53
- Dividend yield
- 0.25%
- 52-week range
- $58.75$89.77
- Volume (live)
- -
- Avg. volume (3M)
- 3.66M
GE HealthCare Technologies (GEHC) Stock Price & Financial Analysis
GE HealthCare Technologies Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $69.31 - $71.70 |
|---|---|
| 52-Week High | $89.77 |
| 52-Week Low | $58.75 |
| Open | $69.33 |
| Volume (last close) | 3.13M |
| Average Volume (3M) | 3.66M |
| Revenue (TTM) | 21.27B |
|---|---|
| Net Income (TTM) | 1.99B |
| Free Cash Flow (TTM) | 1.58B |
| EPS (TTM) | $4.35 |
| Profit Margin | 9.33% |
| Operating Margin | 12.85% |
| Return on Equity (ROE) | 17.69% |
| Debt to Equity | 0.90 |
| Annual Dividend | $0.18 |
|---|---|
| Dividend Yield | 0.25% |
| Payout Ratio | 4.14% |
| Last Dividend Ex-Date | Oct 23, 2026 |
| Market Cap | 32.42B |
|---|---|
| Shares Outstanding | 454.00M |
| P/E Ratio (TTM) | 16.33 |
| Forward P/E | 18.53 |
| Price to Sales (P/S) | 1.52 |
| Price to Book (P/B) | 2.89 |
| EV/EBITDA | 10.98 |
| 50-Day MA | $68.50 |
|---|---|
| 200-Day MA | $70.35 |
| 1-Year Change | −7.56% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
GE HealthCare Technologies at a Glance
As of the Oct 22, 2026 close, GE HealthCare Technologies (GEHC) has a market capitalization of $32.42B. The stock trades at 16.3× trailing earnings, 18.5× forward earnings and 1.5× sales. Over the trailing twelve months it earned $1.99B on revenue of $21.27B (a 9.3% profit margin) and generated $1.58B of free cash flow. Revenue grew 1.4% year over year.
As of its latest reported balance sheet, it holds $2.08B in cash and securities against $10.09B of debt, a net debt position of $8.01B.
GE HealthCare Technologies pays a quarterly dividend totaling $0.18 per share a year, a 0.25% yield at the Oct 22, 2026 close, with a 4% payout ratio and 1 consecutive year of dividend increases.
The share price is down 7.6% over the past year. At $71.42 (the Oct 22, 2026 close) it sits within its 52-week range of $58.75 to $89.77, above its 200-day moving average of $70.35.
Based on 17 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $80.20, 12.3% above the Oct 22, 2026 close.
Frequently Asked Questions About GE HealthCare Technologies
What is the current stock price for GEHC?
As of the Oct 22, 2026 close, GEHC stock trades at $71.42. The 52-week range is $58.75–$89.77, with a day range of $69.31–$71.70.
What is the P/E ratio for GEHC?
As of the Oct 22, 2026 close, GE HealthCare Technologies's trailing twelve-month (TTM) P/E ratio is 16.3, meaning investors pay $16.3 for every $1 of annual earnings. The forward P/E is 18.5, reflecting analyst expectations for future earnings. GE HealthCare Technologies operates in the Healthcare sector.
Does GEHC pay dividends?
Yes, GE HealthCare Technologies pays a 0.25% annual dividend yield as of the Oct 22, 2026 close ($0.18 per share a year). The trailing twelve-month payout ratio is 4.1%. The most recent ex-dividend date was October 23, 2026.
What do analysts recommend for GEHC?
Based on ratings from 17 professional analysts over the last 90 days, the consensus for GEHC is Buy. The average 12-month price target is $80.20, a 12.3% upside from the Oct 22, 2026 close of $71.42.
What is the market cap of GEHC?
As of the Oct 22, 2026 close, GE HealthCare Technologies's market capitalization is $32.42B, classifying it as a large-cap company. GE HealthCare Technologies operates in the Healthcare sector within the Medical Devices industry.